Aug. 16, 2023

The American College of Radiology® (ACR®) submitted comments in response to the Centers for Medicare and Medicaid Services (CMS) National Coverage Analysis (NCA) for Beta Amyloid Positron Emission Tomography (PET) in Dementia and Neurodegenerative Disease (NCD) 220.6.20.

The ACR contends the evidence is sufficient to end the coverage with evidence development (CED) and allow national coverage of beta-amyloid PET. The College strongly urged CMS to reconsider leaving coverage determinations to the discretion of local Medicare Administrative Contractors (MACs) and instead implement a national coverage ruling. If left to local determination, a final ruling for coverage of Aß PET could be significantly delayed and highly variable across geographic regions, further exacerbating existing inequities to access. Swift and broad coverage of Aß PET is imperative at this time when anti-amyloid therapies are being approved by the U.S. Food and Drug Administration (FDA) and highly sought after by patients and their families.

An NCD allowing full coverage without CED would ensure swift and consistent coverage for all Medicare beneficiaries.

ACR will continue to track and monitor policy developments about this clinical topic. The College anticipates a final coverage decision to be released in October. If you have questions regarding NCDs, contact Alicia Blakey, ACR Principal Economic Policy Analyst.


Related ACR News

  • Priscilla J. Slanetz, MD, MPH Named RAN Advocate of the Year

    ACR spoke with Dr. Slanetz about her involvement in advocacy and what the Advocate of the Year award means to her.

    Read more
    Dr. Slanetz receiving the RAN Advocate of the Year
  • Bill Introduced to Expand Access to Lung Cancer Screening

    The bill would enable healthcare organizations to purchase new mobile cancer screening units under a program within the HRSA, with an emphasis on lung cancer.

    Read more
  • ACR Urges HHS to Promote Annual Lung Cancer Screenings

    In a recent comment letter, the College presented updated data that highlights the life-saving potential of lung cancer screening.

    Read more